Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for EBF3
Z-value: 1.35
Motif logo
Transcription factors associated with EBF3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
EBF3
|
ENSG00000108001.9 | EBF transcription factor 3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| EBF3 | hg19_v2_chr10_-_131762105_131762105 | 0.44 | 5.4e-02 | Click! |
Activity profile of EBF3 motif
Sorted Z-values of EBF3 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr11_+_57227981 | 7.71 |
ENST00000335099.3
|
RTN4RL2
|
reticulon 4 receptor-like 2 |
| chr17_-_15168624 | 5.25 |
ENST00000312280.3
ENST00000494511.1 ENST00000580584.1 |
PMP22
|
peripheral myelin protein 22 |
| chr11_-_117698787 | 5.15 |
ENST00000260287.2
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr8_-_19459993 | 5.08 |
ENST00000454498.2
ENST00000520003.1 |
CSGALNACT1
|
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
| chr11_-_117699413 | 5.06 |
ENST00000528014.1
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr15_+_66994561 | 5.03 |
ENST00000288840.5
|
SMAD6
|
SMAD family member 6 |
| chr14_+_105953246 | 4.97 |
ENST00000392531.3
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
| chr14_+_105953204 | 4.87 |
ENST00000409393.2
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
| chr1_-_153517473 | 4.84 |
ENST00000368715.1
|
S100A4
|
S100 calcium binding protein A4 |
| chr14_+_105952648 | 4.71 |
ENST00000330233.7
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
| chr1_-_1051455 | 4.50 |
ENST00000379339.1
ENST00000480643.1 ENST00000434641.1 ENST00000421241.2 |
C1orf159
|
chromosome 1 open reading frame 159 |
| chr17_+_73606766 | 4.49 |
ENST00000578462.1
|
MYO15B
|
myosin XVB pseudogene |
| chr17_+_47074758 | 4.46 |
ENST00000290341.3
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1 |
| chr17_-_43045439 | 4.30 |
ENST00000253407.3
|
C1QL1
|
complement component 1, q subcomponent-like 1 |
| chr19_-_6591113 | 4.26 |
ENST00000423145.3
ENST00000245903.3 |
CD70
|
CD70 molecule |
| chr11_-_117698765 | 3.83 |
ENST00000532119.1
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr19_-_38743878 | 3.82 |
ENST00000587515.1
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
| chr22_-_30960876 | 3.62 |
ENST00000401975.1
ENST00000428682.1 ENST00000423299.1 |
GAL3ST1
|
galactose-3-O-sulfotransferase 1 |
| chr11_+_114128522 | 3.54 |
ENST00000535401.1
|
NNMT
|
nicotinamide N-methyltransferase |
| chr11_+_1244288 | 3.48 |
ENST00000529681.1
ENST00000447027.1 |
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming |
| chr12_-_49259643 | 3.36 |
ENST00000309739.5
|
RND1
|
Rho family GTPase 1 |
| chr11_-_67120974 | 3.25 |
ENST00000539074.1
ENST00000312419.3 |
POLD4
|
polymerase (DNA-directed), delta 4, accessory subunit |
| chr3_-_142608001 | 3.19 |
ENST00000295992.3
|
PCOLCE2
|
procollagen C-endopeptidase enhancer 2 |
| chr19_+_39904168 | 3.13 |
ENST00000438123.1
ENST00000409797.2 ENST00000451354.2 |
PLEKHG2
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 2 |
| chr19_+_4229495 | 3.09 |
ENST00000221847.5
|
EBI3
|
Epstein-Barr virus induced 3 |
| chr20_+_2673383 | 3.06 |
ENST00000380648.4
ENST00000342725.5 |
EBF4
|
early B-cell factor 4 |
| chr19_+_55795493 | 3.03 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
| chr14_-_23791484 | 2.92 |
ENST00000594872.1
|
AL049829.1
|
Uncharacterized protein |
| chr11_-_9482010 | 2.71 |
ENST00000596206.1
|
AC132192.1
|
LOC644656 protein; Uncharacterized protein |
| chr12_+_21679220 | 2.62 |
ENST00000256969.2
|
C12orf39
|
chromosome 12 open reading frame 39 |
| chr7_-_155604967 | 2.50 |
ENST00000297261.2
|
SHH
|
sonic hedgehog |
| chr2_+_120189422 | 2.47 |
ENST00000306406.4
|
TMEM37
|
transmembrane protein 37 |
| chr12_+_53443963 | 2.47 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
| chr2_+_27070964 | 2.45 |
ENST00000288699.6
|
DPYSL5
|
dihydropyrimidinase-like 5 |
| chr16_+_2083265 | 2.45 |
ENST00000565855.1
ENST00000566198.1 |
SLC9A3R2
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 |
| chr10_+_101089107 | 2.43 |
ENST00000446890.1
ENST00000370528.3 |
CNNM1
|
cyclin M1 |
| chr12_+_53443680 | 2.43 |
ENST00000314250.6
ENST00000451358.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
| chr19_-_55881741 | 2.42 |
ENST00000264563.2
ENST00000590625.1 ENST00000585513.1 |
IL11
|
interleukin 11 |
| chr3_-_142607740 | 2.41 |
ENST00000485766.1
|
PCOLCE2
|
procollagen C-endopeptidase enhancer 2 |
| chr1_-_21995794 | 2.38 |
ENST00000542643.2
ENST00000374765.4 ENST00000317967.7 |
RAP1GAP
|
RAP1 GTPase activating protein |
| chr1_+_110453203 | 2.35 |
ENST00000357302.4
ENST00000344188.5 ENST00000329608.6 |
CSF1
|
colony stimulating factor 1 (macrophage) |
| chr5_+_139028510 | 2.34 |
ENST00000502336.1
ENST00000520967.1 ENST00000511048.1 |
CXXC5
|
CXXC finger protein 5 |
| chr17_+_77021702 | 2.32 |
ENST00000392445.2
ENST00000354124.3 |
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
| chr11_+_48002076 | 2.30 |
ENST00000418331.2
ENST00000440289.2 |
PTPRJ
|
protein tyrosine phosphatase, receptor type, J |
| chr7_-_100881041 | 2.24 |
ENST00000412417.1
ENST00000414035.1 |
CLDN15
|
claudin 15 |
| chr11_+_22646739 | 2.22 |
ENST00000428556.2
|
AC103801.2
|
AC103801.2 |
| chr5_-_132948216 | 2.20 |
ENST00000265342.7
|
FSTL4
|
follistatin-like 4 |
| chr17_-_79881408 | 2.18 |
ENST00000392366.3
|
MAFG
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G |
| chr11_-_69294647 | 2.16 |
ENST00000542064.1
|
AP000439.3
|
AP000439.3 |
| chr19_+_2476116 | 2.14 |
ENST00000215631.4
ENST00000587345.1 |
GADD45B
|
growth arrest and DNA-damage-inducible, beta |
| chr19_+_55996316 | 2.12 |
ENST00000205194.4
|
NAT14
|
N-acetyltransferase 14 (GCN5-related, putative) |
| chr7_-_100881109 | 2.09 |
ENST00000308344.5
|
CLDN15
|
claudin 15 |
| chr19_+_41107249 | 2.07 |
ENST00000396819.3
|
LTBP4
|
latent transforming growth factor beta binding protein 4 |
| chr3_+_32280159 | 2.06 |
ENST00000458535.2
ENST00000307526.3 |
CMTM8
|
CKLF-like MARVEL transmembrane domain containing 8 |
| chr1_-_41950342 | 2.06 |
ENST00000372587.4
|
EDN2
|
endothelin 2 |
| chr4_+_4861385 | 2.06 |
ENST00000382723.4
|
MSX1
|
msh homeobox 1 |
| chr16_-_31076332 | 2.04 |
ENST00000539836.3
ENST00000535577.1 ENST00000442862.2 |
ZNF668
|
zinc finger protein 668 |
| chr17_-_73874654 | 2.03 |
ENST00000254816.2
|
TRIM47
|
tripartite motif containing 47 |
| chr7_+_73082152 | 1.95 |
ENST00000324941.4
ENST00000451519.1 |
VPS37D
|
vacuolar protein sorting 37 homolog D (S. cerevisiae) |
| chr11_+_48002279 | 1.93 |
ENST00000534219.1
ENST00000527952.1 |
PTPRJ
|
protein tyrosine phosphatase, receptor type, J |
| chr17_+_77020146 | 1.93 |
ENST00000579760.1
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
| chr14_-_54418598 | 1.90 |
ENST00000609748.1
ENST00000558961.1 |
BMP4
|
bone morphogenetic protein 4 |
| chr19_-_40331345 | 1.89 |
ENST00000597224.1
|
FBL
|
fibrillarin |
| chrX_+_69509927 | 1.89 |
ENST00000374403.3
|
KIF4A
|
kinesin family member 4A |
| chr11_-_65381643 | 1.88 |
ENST00000309100.3
ENST00000529839.1 ENST00000526293.1 |
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11 |
| chr17_+_77020224 | 1.87 |
ENST00000339142.2
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
| chr5_-_58295712 | 1.86 |
ENST00000317118.8
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
| chr17_+_77020325 | 1.79 |
ENST00000311661.4
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
| chr1_-_11751665 | 1.78 |
ENST00000376667.3
ENST00000235310.3 |
MAD2L2
|
MAD2 mitotic arrest deficient-like 2 (yeast) |
| chr1_-_24438664 | 1.77 |
ENST00000374434.3
ENST00000330966.7 ENST00000329601.7 |
MYOM3
|
myomesin 3 |
| chr9_+_140317802 | 1.77 |
ENST00000341349.2
ENST00000392815.2 |
NOXA1
|
NADPH oxidase activator 1 |
| chr5_-_41510656 | 1.73 |
ENST00000377801.3
|
PLCXD3
|
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
| chr1_+_110453514 | 1.73 |
ENST00000369802.3
ENST00000420111.2 |
CSF1
|
colony stimulating factor 1 (macrophage) |
| chr8_+_62200509 | 1.70 |
ENST00000519846.1
ENST00000518592.1 ENST00000325897.4 |
CLVS1
|
clavesin 1 |
| chr1_-_11751529 | 1.68 |
ENST00000376672.1
|
MAD2L2
|
MAD2 mitotic arrest deficient-like 2 (yeast) |
| chr19_+_984313 | 1.67 |
ENST00000251289.5
ENST00000587001.2 ENST00000607440.1 |
WDR18
|
WD repeat domain 18 |
| chr2_-_188378368 | 1.67 |
ENST00000392365.1
ENST00000435414.1 |
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
| chr10_+_112404132 | 1.66 |
ENST00000369519.3
|
RBM20
|
RNA binding motif protein 20 |
| chr7_+_75831181 | 1.64 |
ENST00000388802.4
ENST00000326382.8 |
SRRM3
|
serine/arginine repetitive matrix 3 |
| chr4_+_980785 | 1.62 |
ENST00000247933.4
ENST00000453894.1 |
IDUA
|
iduronidase, alpha-L- |
| chr16_-_29478016 | 1.59 |
ENST00000549858.1
ENST00000551411.1 |
RP11-345J4.3
|
Uncharacterized protein |
| chr2_+_27071045 | 1.58 |
ENST00000401478.1
|
DPYSL5
|
dihydropyrimidinase-like 5 |
| chr16_+_3068393 | 1.56 |
ENST00000573001.1
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A |
| chr3_-_129375556 | 1.55 |
ENST00000510323.1
|
TMCC1
|
transmembrane and coiled-coil domain family 1 |
| chr3_-_88108192 | 1.55 |
ENST00000309534.6
|
CGGBP1
|
CGG triplet repeat binding protein 1 |
| chr8_+_145490549 | 1.54 |
ENST00000340695.2
|
SCXA
|
scleraxis homolog A (mouse) |
| chr12_-_58135903 | 1.53 |
ENST00000257897.3
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
| chr10_+_133918175 | 1.53 |
ENST00000298622.4
|
JAKMIP3
|
Janus kinase and microtubule interacting protein 3 |
| chr10_+_4868439 | 1.47 |
ENST00000298375.7
|
AKR1E2
|
aldo-keto reductase family 1, member E2 |
| chr8_+_21912328 | 1.45 |
ENST00000432128.1
ENST00000443491.2 ENST00000517600.1 ENST00000523782.2 |
DMTN
|
dematin actin binding protein |
| chrX_-_10645773 | 1.44 |
ENST00000453318.2
|
MID1
|
midline 1 (Opitz/BBB syndrome) |
| chr17_+_7308172 | 1.43 |
ENST00000575301.1
|
NLGN2
|
neuroligin 2 |
| chr19_+_55996565 | 1.39 |
ENST00000587400.1
|
NAT14
|
N-acetyltransferase 14 (GCN5-related, putative) |
| chrX_-_14891150 | 1.39 |
ENST00000452869.1
ENST00000398334.1 ENST00000324138.3 |
FANCB
|
Fanconi anemia, complementation group B |
| chr19_+_55996543 | 1.38 |
ENST00000591590.1
|
NAT14
|
N-acetyltransferase 14 (GCN5-related, putative) |
| chr15_+_76030311 | 1.36 |
ENST00000543887.1
|
AC019294.1
|
AC019294.1 |
| chr16_+_71392616 | 1.36 |
ENST00000349553.5
ENST00000302628.4 ENST00000562305.1 |
CALB2
|
calbindin 2 |
| chr8_+_22436248 | 1.35 |
ENST00000308354.7
|
PDLIM2
|
PDZ and LIM domain 2 (mystique) |
| chrX_-_49056635 | 1.35 |
ENST00000472598.1
ENST00000538567.1 ENST00000479808.1 ENST00000263233.4 |
SYP
|
synaptophysin |
| chr2_-_97523721 | 1.35 |
ENST00000393537.4
|
ANKRD39
|
ankyrin repeat domain 39 |
| chr20_-_47444420 | 1.33 |
ENST00000371941.3
ENST00000396220.1 |
PREX1
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
| chr2_+_27301435 | 1.32 |
ENST00000380320.4
|
EMILIN1
|
elastin microfibril interfacer 1 |
| chrX_+_38420623 | 1.31 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
| chr9_-_44402427 | 1.30 |
ENST00000540551.1
|
BX088651.1
|
LOC100126582 protein; Uncharacterized protein |
| chr7_-_100287071 | 1.30 |
ENST00000275732.5
|
GIGYF1
|
GRB10 interacting GYF protein 1 |
| chr11_+_65408273 | 1.30 |
ENST00000394227.3
|
SIPA1
|
signal-induced proliferation-associated 1 |
| chr3_-_52273098 | 1.30 |
ENST00000499914.2
ENST00000305533.5 ENST00000597542.1 |
TWF2
TLR9
|
twinfilin actin-binding protein 2 toll-like receptor 9 |
| chrX_+_49019061 | 1.30 |
ENST00000376339.1
ENST00000425661.2 ENST00000458388.1 ENST00000412696.2 |
MAGIX
|
MAGI family member, X-linked |
| chrX_+_192989 | 1.29 |
ENST00000399012.1
ENST00000430923.2 |
PLCXD1
|
phosphatidylinositol-specific phospholipase C, X domain containing 1 |
| chr8_+_22446763 | 1.28 |
ENST00000450780.2
ENST00000430850.2 ENST00000447849.1 |
AC037459.4
|
Uncharacterized protein |
| chr9_-_139581848 | 1.28 |
ENST00000538402.1
ENST00000371694.3 |
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
| chr1_+_110198689 | 1.26 |
ENST00000369836.4
|
GSTM4
|
glutathione S-transferase mu 4 |
| chrX_+_38420783 | 1.26 |
ENST00000422612.2
ENST00000286824.6 ENST00000545599.1 |
TSPAN7
|
tetraspanin 7 |
| chr1_-_247495045 | 1.26 |
ENST00000294753.4
ENST00000366498.2 |
ZNF496
|
zinc finger protein 496 |
| chr8_-_25281747 | 1.25 |
ENST00000421054.2
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
| chr5_-_41510725 | 1.24 |
ENST00000328457.3
|
PLCXD3
|
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
| chr1_+_110198714 | 1.23 |
ENST00000336075.5
ENST00000326729.5 |
GSTM4
|
glutathione S-transferase mu 4 |
| chr1_+_110453462 | 1.23 |
ENST00000488198.1
|
CSF1
|
colony stimulating factor 1 (macrophage) |
| chr20_-_62203808 | 1.23 |
ENST00000467148.1
|
HELZ2
|
helicase with zinc finger 2, transcriptional coactivator |
| chr9_-_139581875 | 1.23 |
ENST00000371696.2
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
| chr6_-_41908428 | 1.23 |
ENST00000505064.1
|
CCND3
|
cyclin D3 |
| chr16_-_68482440 | 1.22 |
ENST00000219334.5
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) |
| chr17_-_7832753 | 1.22 |
ENST00000303790.2
|
KCNAB3
|
potassium voltage-gated channel, shaker-related subfamily, beta member 3 |
| chr17_+_73452545 | 1.22 |
ENST00000314256.7
|
KIAA0195
|
KIAA0195 |
| chr16_+_57126482 | 1.22 |
ENST00000537605.1
ENST00000535318.2 |
CPNE2
|
copine II |
| chr2_-_46769694 | 1.22 |
ENST00000522587.1
|
ATP6V1E2
|
ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2 |
| chr2_+_200775971 | 1.21 |
ENST00000319974.5
|
C2orf69
|
chromosome 2 open reading frame 69 |
| chrX_+_152990302 | 1.18 |
ENST00000218104.3
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1 |
| chrX_+_69509870 | 1.18 |
ENST00000374388.3
|
KIF4A
|
kinesin family member 4A |
| chr4_+_980825 | 1.18 |
ENST00000502910.1
ENST00000504568.1 |
IDUA
|
iduronidase, alpha-L- |
| chr9_-_138987115 | 1.15 |
ENST00000277554.2
|
NACC2
|
NACC family member 2, BEN and BTB (POZ) domain containing |
| chr12_-_120805872 | 1.15 |
ENST00000546985.1
|
MSI1
|
musashi RNA-binding protein 1 |
| chr17_-_80023659 | 1.15 |
ENST00000578907.1
ENST00000577907.1 ENST00000578176.1 ENST00000582529.1 |
DUS1L
|
dihydrouridine synthase 1-like (S. cerevisiae) |
| chr17_+_30594823 | 1.15 |
ENST00000536287.1
|
RHBDL3
|
rhomboid, veinlet-like 3 (Drosophila) |
| chr11_+_64879317 | 1.14 |
ENST00000526809.1
ENST00000279263.7 ENST00000524986.1 ENST00000534371.1 ENST00000540748.1 ENST00000525385.1 ENST00000345348.5 ENST00000531321.1 ENST00000529414.1 ENST00000526085.1 ENST00000530750.1 |
TM7SF2
|
transmembrane 7 superfamily member 2 |
| chrX_-_48827976 | 1.14 |
ENST00000218176.3
|
KCND1
|
potassium voltage-gated channel, Shal-related subfamily, member 1 |
| chr16_+_30662085 | 1.12 |
ENST00000569864.1
|
PRR14
|
proline rich 14 |
| chr19_+_50180409 | 1.09 |
ENST00000391851.4
|
PRMT1
|
protein arginine methyltransferase 1 |
| chr10_-_47151341 | 1.06 |
ENST00000422732.2
|
LINC00842
|
long intergenic non-protein coding RNA 842 |
| chr7_-_150946015 | 1.05 |
ENST00000262188.8
|
SMARCD3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
| chr19_-_40324255 | 1.05 |
ENST00000593685.1
ENST00000600611.1 |
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
| chr19_+_49128209 | 1.04 |
ENST00000599748.1
ENST00000443164.1 ENST00000599029.1 |
SPHK2
|
sphingosine kinase 2 |
| chr20_-_44516256 | 1.04 |
ENST00000372519.3
|
SPATA25
|
spermatogenesis associated 25 |
| chr3_-_149293990 | 1.03 |
ENST00000472417.1
|
WWTR1
|
WW domain containing transcription regulator 1 |
| chr14_+_96671016 | 1.03 |
ENST00000542454.2
ENST00000554311.1 ENST00000306005.3 ENST00000539359.1 ENST00000553811.1 |
BDKRB2
RP11-404P21.8
|
bradykinin receptor B2 Uncharacterized protein |
| chr1_+_46049706 | 1.02 |
ENST00000527470.1
ENST00000525515.1 ENST00000537798.1 ENST00000402363.3 ENST00000528238.1 ENST00000350030.3 ENST00000470768.1 ENST00000372052.4 ENST00000351223.3 |
NASP
|
nuclear autoantigenic sperm protein (histone-binding) |
| chr2_+_128177458 | 1.01 |
ENST00000409048.1
ENST00000422777.3 |
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa) |
| chr7_+_29874341 | 1.01 |
ENST00000409290.1
ENST00000242140.5 |
WIPF3
|
WAS/WASL interacting protein family, member 3 |
| chr19_-_59010565 | 1.01 |
ENST00000594786.1
|
SLC27A5
|
solute carrier family 27 (fatty acid transporter), member 5 |
| chr8_+_145582217 | 1.01 |
ENST00000530047.1
ENST00000527078.1 |
SLC52A2
|
solute carrier family 52 (riboflavin transporter), member 2 |
| chr5_-_172198190 | 1.00 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
| chr17_-_27053216 | 1.00 |
ENST00000292090.3
|
TLCD1
|
TLC domain containing 1 |
| chr2_+_219135115 | 0.99 |
ENST00000248451.3
ENST00000273077.4 |
PNKD
|
paroxysmal nonkinesigenic dyskinesia |
| chr8_+_145582231 | 0.99 |
ENST00000526338.1
ENST00000402965.1 ENST00000534725.1 ENST00000532887.1 ENST00000329994.2 |
SLC52A2
|
solute carrier family 52 (riboflavin transporter), member 2 |
| chr22_-_24316648 | 0.98 |
ENST00000403754.3
ENST00000430101.2 ENST00000398344.4 |
DDT
|
D-dopachrome tautomerase |
| chr1_-_242612726 | 0.98 |
ENST00000459864.1
|
PLD5
|
phospholipase D family, member 5 |
| chr19_-_49843539 | 0.98 |
ENST00000602554.1
ENST00000358234.4 |
CTC-301O7.4
|
CTC-301O7.4 |
| chr17_-_73839792 | 0.96 |
ENST00000590762.1
|
UNC13D
|
unc-13 homolog D (C. elegans) |
| chr19_+_41620335 | 0.96 |
ENST00000331105.2
|
CYP2F1
|
cytochrome P450, family 2, subfamily F, polypeptide 1 |
| chr7_-_99698338 | 0.96 |
ENST00000354230.3
ENST00000425308.1 |
MCM7
|
minichromosome maintenance complex component 7 |
| chr15_+_84841242 | 0.95 |
ENST00000558195.1
|
RP11-182J1.16
|
ubiquitin-conjugating enzyme E2Q family member 2-like |
| chr7_-_27187393 | 0.95 |
ENST00000222728.3
|
HOXA6
|
homeobox A6 |
| chr8_+_145582633 | 0.95 |
ENST00000540505.1
|
SLC52A2
|
solute carrier family 52 (riboflavin transporter), member 2 |
| chr17_+_78194205 | 0.95 |
ENST00000573809.1
ENST00000361193.3 ENST00000574967.1 ENST00000576126.1 ENST00000411502.3 ENST00000546047.2 |
SLC26A11
|
solute carrier family 26 (anion exchanger), member 11 |
| chr1_-_242612779 | 0.94 |
ENST00000427495.1
|
PLD5
|
phospholipase D family, member 5 |
| chr3_+_150804676 | 0.94 |
ENST00000474524.1
ENST00000273432.4 |
MED12L
|
mediator complex subunit 12-like |
| chr17_-_73901494 | 0.93 |
ENST00000309352.3
|
MRPL38
|
mitochondrial ribosomal protein L38 |
| chr7_-_98467629 | 0.92 |
ENST00000339375.4
|
TMEM130
|
transmembrane protein 130 |
| chr3_-_185270383 | 0.91 |
ENST00000296252.4
|
LIPH
|
lipase, member H |
| chr10_+_11784360 | 0.91 |
ENST00000379215.4
ENST00000420401.1 |
ECHDC3
|
enoyl CoA hydratase domain containing 3 |
| chr7_+_26438187 | 0.91 |
ENST00000439120.1
ENST00000430548.1 ENST00000421862.1 ENST00000449537.1 ENST00000420774.1 ENST00000418758.2 |
AC004540.5
|
AC004540.5 |
| chr7_-_100240328 | 0.91 |
ENST00000462107.1
|
TFR2
|
transferrin receptor 2 |
| chr20_-_35402123 | 0.91 |
ENST00000373740.3
ENST00000426836.1 ENST00000373745.3 ENST00000448110.2 ENST00000438549.1 ENST00000447406.1 ENST00000373750.4 ENST00000373734.4 |
DSN1
|
DSN1, MIS12 kinetochore complex component |
| chr11_-_72432950 | 0.89 |
ENST00000426523.1
ENST00000429686.1 |
ARAP1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
| chr20_+_43211149 | 0.89 |
ENST00000372886.1
|
PKIG
|
protein kinase (cAMP-dependent, catalytic) inhibitor gamma |
| chr17_-_61777090 | 0.86 |
ENST00000578061.1
|
LIMD2
|
LIM domain containing 2 |
| chr17_-_34890732 | 0.85 |
ENST00000268852.9
|
MYO19
|
myosin XIX |
| chr15_-_102192567 | 0.85 |
ENST00000333202.3
ENST00000428002.2 ENST00000559107.1 ENST00000347970.3 |
TM2D3
|
TM2 domain containing 3 |
| chr19_+_33865218 | 0.85 |
ENST00000585933.2
|
CEBPG
|
CCAAT/enhancer binding protein (C/EBP), gamma |
| chr17_+_4046964 | 0.84 |
ENST00000573984.1
|
CYB5D2
|
cytochrome b5 domain containing 2 |
| chr4_+_7194247 | 0.83 |
ENST00000507866.2
|
SORCS2
|
sortilin-related VPS10 domain containing receptor 2 |
| chr2_+_206950095 | 0.83 |
ENST00000435627.1
|
AC007383.3
|
AC007383.3 |
| chr7_-_150974494 | 0.83 |
ENST00000392811.2
|
SMARCD3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
| chr15_-_90233907 | 0.83 |
ENST00000561224.1
|
PEX11A
|
peroxisomal biogenesis factor 11 alpha |
| chr1_-_1310530 | 0.82 |
ENST00000338370.3
ENST00000321751.5 ENST00000378853.3 |
AURKAIP1
|
aurora kinase A interacting protein 1 |
| chr17_+_14277419 | 0.81 |
ENST00000436469.1
|
AC022816.2
|
AC022816.2 |
| chr10_+_95848824 | 0.80 |
ENST00000371385.3
ENST00000371375.1 |
PLCE1
|
phospholipase C, epsilon 1 |
| chr19_+_50180507 | 0.80 |
ENST00000454376.2
ENST00000524771.1 |
PRMT1
|
protein arginine methyltransferase 1 |
| chr14_-_45722360 | 0.80 |
ENST00000451174.1
|
MIS18BP1
|
MIS18 binding protein 1 |
| chr17_-_34890759 | 0.80 |
ENST00000431794.3
|
MYO19
|
myosin XIX |
| chr17_+_43971643 | 0.80 |
ENST00000344290.5
ENST00000262410.5 ENST00000351559.5 ENST00000340799.5 ENST00000535772.1 ENST00000347967.5 |
MAPT
|
microtubule-associated protein tau |
| chr3_-_128212016 | 0.79 |
ENST00000498200.1
ENST00000341105.2 |
GATA2
|
GATA binding protein 2 |
| chr17_-_7082861 | 0.79 |
ENST00000269299.3
|
ASGR1
|
asialoglycoprotein receptor 1 |
| chr15_-_50411412 | 0.79 |
ENST00000284509.6
|
ATP8B4
|
ATPase, class I, type 8B, member 4 |
| chr9_+_136325089 | 0.78 |
ENST00000291722.7
ENST00000316948.4 ENST00000540581.1 |
CACFD1
|
calcium channel flower domain containing 1 |
| chr19_-_39108643 | 0.77 |
ENST00000396857.2
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
| chr3_+_173116225 | 0.77 |
ENST00000457714.1
|
NLGN1
|
neuroligin 1 |
| chr12_+_38710555 | 0.77 |
ENST00000551464.1
|
ALG10B
|
ALG10B, alpha-1,2-glucosyltransferase |
| chr9_-_35619539 | 0.77 |
ENST00000396757.1
|
CD72
|
CD72 molecule |
| chr4_-_140223614 | 0.76 |
ENST00000394223.1
|
NDUFC1
|
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa |
Network of associatons between targets according to the STRING database.
First level regulatory network of EBF3
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 14.5 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 1.4 | 4.3 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 1.3 | 2.5 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 1.2 | 6.0 | GO:1902228 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 1.0 | 7.9 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.8 | 2.4 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.7 | 2.2 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.7 | 14.6 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.7 | 5.0 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.7 | 2.1 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.6 | 5.1 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.6 | 1.9 | GO:0033967 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.6 | 2.9 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.5 | 2.1 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.5 | 3.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.4 | 4.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.4 | 5.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.4 | 1.9 | GO:0061150 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.4 | 1.9 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 0.3 | 2.4 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.3 | 2.4 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.3 | 1.0 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.3 | 1.0 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
| 0.3 | 2.8 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.3 | 1.3 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.3 | 3.6 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.3 | 1.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.3 | 3.7 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.3 | 1.1 | GO:0072248 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.3 | 1.0 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.3 | 1.0 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.3 | 1.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.3 | 1.0 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.2 | 1.0 | GO:0002432 | granuloma formation(GO:0002432) |
| 0.2 | 1.7 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.2 | 4.2 | GO:0060242 | contact inhibition(GO:0060242) |
| 0.2 | 5.3 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.2 | 1.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.2 | 2.7 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.2 | 7.7 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.2 | 0.8 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.2 | 0.6 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.2 | 1.1 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.2 | 1.9 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.2 | 0.5 | GO:1904530 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.2 | 3.4 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.2 | 1.7 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.2 | 0.7 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.2 | 3.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.2 | 0.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.2 | 0.6 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.2 | 0.9 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.2 | 1.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 0.8 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.2 | 0.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.2 | 0.9 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.1 | 2.8 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.1 | 2.8 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
| 0.1 | 1.5 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.1 | 4.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 0.7 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.1 | 0.4 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 | 0.5 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 | 0.4 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.1 | 0.5 | GO:0090293 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.1 | 0.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 | 1.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.1 | 0.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 | 4.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 | 0.5 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.1 | 0.4 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 | 0.5 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.1 | 0.5 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
| 0.1 | 1.9 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.1 | 1.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 0.7 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 | 0.5 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
| 0.1 | 2.5 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.1 | 0.3 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.1 | 0.9 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) |
| 0.1 | 1.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.1 | 1.8 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 0.8 | GO:0044375 | peroxisome membrane biogenesis(GO:0016557) regulation of peroxisome size(GO:0044375) |
| 0.1 | 0.8 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.1 | 1.0 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.1 | 0.5 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.1 | 1.0 | GO:1902218 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.1 | 1.7 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 3.3 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.1 | 1.0 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.1 | 1.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 0.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 | 0.2 | GO:0061508 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.1 | 0.5 | GO:0097473 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 0.1 | 0.3 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.1 | 0.3 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 | 0.4 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.1 | 0.2 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.1 | 0.3 | GO:0039507 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 0.1 | 0.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
| 0.1 | 0.2 | GO:0061184 | Spemann organizer formation(GO:0060061) positive regulation of dermatome development(GO:0061184) |
| 0.1 | 0.2 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 0.1 | 1.0 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.1 | 0.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.1 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.1 | 0.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.1 | 0.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 | 0.2 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 | 2.0 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.1 | 0.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.1 | 1.0 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 0.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.0 | 0.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.0 | 1.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 0.0 | 0.2 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.0 | 0.3 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 | 0.4 | GO:0032621 | interleukin-18 production(GO:0032621) |
| 0.0 | 0.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.0 | 0.6 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.0 | 1.9 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.0 | 0.4 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.0 | 0.1 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
| 0.0 | 0.3 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.0 | 0.5 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.0 | 0.1 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
| 0.0 | 1.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.0 | 0.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.0 | 0.2 | GO:0031577 | spindle checkpoint(GO:0031577) |
| 0.0 | 0.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 | 0.2 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.0 | 1.8 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.0 | 1.2 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.0 | 0.2 | GO:1902075 | cellular response to salt(GO:1902075) |
| 0.0 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.0 | 0.5 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.0 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.0 | 2.0 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.0 | 6.0 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.0 | 0.8 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.0 | 0.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.0 | 0.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 | 0.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.0 | 3.0 | GO:0051298 | centrosome duplication(GO:0051298) |
| 0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.0 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 | 1.0 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
| 0.0 | 0.1 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 0.0 | 1.2 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.0 | 0.5 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.0 | 1.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.0 | 0.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.0 | 0.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.0 | 0.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.0 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 | 0.6 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
| 0.0 | 0.1 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.0 | 3.0 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.0 | 0.6 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 1.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.0 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
| 0.0 | 0.7 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.0 | 0.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.0 | 0.5 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.0 | 1.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.0 | 1.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 | 0.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.0 | 0.8 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 | 2.7 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 1.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.0 | 0.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.0 | 1.6 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 | 0.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.0 | 0.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.0 | 1.9 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.0 | 0.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.0 | 0.7 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 | 0.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 | 1.6 | GO:0030641 | regulation of cellular pH(GO:0030641) |
| 0.0 | 0.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
| 0.0 | 0.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.0 | 0.5 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 | 1.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
| 0.0 | 0.6 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.0 | 0.0 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.0 | 0.6 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
| 0.0 | 0.4 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
| 0.0 | 0.4 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.0 | 1.7 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.0 | 2.1 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) |
| 0.0 | 0.4 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 | 0.2 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
| 0.0 | 0.6 | GO:0045214 | sarcomere organization(GO:0045214) |
| 0.0 | 0.8 | GO:0060612 | adipose tissue development(GO:0060612) |
| 0.0 | 2.4 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
| 0.0 | 1.0 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 | 0.9 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.0 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.0 | 0.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.0 | 4.7 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
| 0.0 | 0.4 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.0 | 0.8 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.0 | 1.4 | GO:0051289 | protein homotetramerization(GO:0051289) |
| 0.0 | 0.2 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 4.3 | GO:0044301 | climbing fiber(GO:0044301) |
| 0.9 | 6.0 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.7 | 3.5 | GO:0070701 | mucus layer(GO:0070701) |
| 0.6 | 3.5 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.6 | 14.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.5 | 3.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.4 | 1.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
| 0.3 | 1.9 | GO:0005921 | gap junction(GO:0005921) |
| 0.3 | 1.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.3 | 0.9 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) condensed chromosome inner kinetochore(GO:0000939) |
| 0.3 | 4.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.2 | 0.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.2 | 1.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.2 | 1.2 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.2 | 0.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.2 | 0.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.1 | 5.3 | GO:0043218 | compact myelin(GO:0043218) |
| 0.1 | 1.3 | GO:0032009 | early phagosome(GO:0032009) |
| 0.1 | 0.7 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.1 | 0.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 0.1 | 1.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.1 | 2.4 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 3.7 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.1 | 6.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 1.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 1.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.1 | 0.4 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.1 | 2.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 0.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 0.5 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.1 | 0.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.1 | 8.3 | GO:0016459 | myosin complex(GO:0016459) |
| 0.1 | 0.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.1 | 5.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.1 | 0.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.1 | 4.2 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 2.1 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.1 | 1.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.1 | 0.9 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.0 | 7.1 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 1.0 | GO:0042555 | MCM complex(GO:0042555) |
| 0.0 | 0.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.0 | 1.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
| 0.0 | 1.0 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.0 | 0.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.0 | 0.6 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.0 | 0.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.0 | 0.6 | GO:0044754 | autolysosome(GO:0044754) |
| 0.0 | 0.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.0 | 2.9 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.0 | 2.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.0 | 0.1 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 0.0 | 1.5 | GO:0000791 | euchromatin(GO:0000791) |
| 0.0 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.0 | 1.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.0 | 1.5 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.0 | 0.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.0 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.0 | 0.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.0 | 1.7 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.0 | 1.0 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 7.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.3 | GO:0097433 | dense body(GO:0097433) |
| 0.0 | 1.1 | GO:0030315 | T-tubule(GO:0030315) |
| 0.0 | 0.8 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 0.8 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.0 | 2.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 1.1 | GO:0005844 | polysome(GO:0005844) |
| 0.0 | 1.7 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 0.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 0.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
| 0.0 | 2.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.0 | 0.9 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.0 | 1.0 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.0 | 0.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.0 | GO:0070698 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) type I activin receptor binding(GO:0070698) |
| 0.9 | 3.5 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.7 | 6.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.7 | 5.1 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
| 0.7 | 15.0 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.7 | 14.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.6 | 1.9 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.6 | 2.9 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.5 | 1.5 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
| 0.5 | 1.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.4 | 1.3 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.4 | 1.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.4 | 2.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.4 | 4.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.4 | 1.1 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.3 | 1.0 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
| 0.3 | 1.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.3 | 1.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.3 | 1.0 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.3 | 1.2 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.3 | 3.6 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.3 | 0.9 | GO:0016250 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
| 0.3 | 2.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.3 | 2.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.3 | 2.4 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.2 | 1.0 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.2 | 0.9 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.2 | 0.7 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
| 0.2 | 2.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.2 | 0.8 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.2 | 0.7 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.2 | 1.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.2 | 0.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.2 | 1.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.2 | 2.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.2 | 3.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.2 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 1.0 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.1 | 2.8 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.1 | 1.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.1 | 1.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.1 | 0.5 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.1 | 1.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.1 | 1.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.1 | 1.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 1.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.1 | 0.6 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.1 | 3.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 0.8 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.1 | 0.4 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.1 | 0.6 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.1 | 0.4 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.1 | 2.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 0.4 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.1 | 1.7 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.4 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.1 | 4.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 2.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 2.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 1.9 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.1 | 3.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 4.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.1 | 0.4 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.1 | 3.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.1 | 0.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.1 | 5.3 | GO:0016504 | peptidase activator activity(GO:0016504) |
| 0.1 | 2.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.1 | 1.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.1 | 0.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.1 | 2.1 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.1 | 0.2 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 0.1 | 0.9 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.1 | 0.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.1 | 1.0 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.1 | 0.3 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.1 | 5.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.1 | 0.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.0 | 0.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.0 | 0.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.0 | 0.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.0 | 0.4 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.0 | 0.3 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.0 | 1.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.0 | 3.5 | GO:0043621 | protein self-association(GO:0043621) |
| 0.0 | 1.0 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.0 | 0.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.0 | 1.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.0 | 0.3 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.0 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.0 | 0.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.0 | 0.4 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.0 | 6.2 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.0 | 1.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.0 | 0.2 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.0 | 5.0 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
| 0.0 | 0.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.0 | 0.8 | GO:0017171 | serine-type peptidase activity(GO:0008236) serine hydrolase activity(GO:0017171) |
| 0.0 | 0.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.0 | 4.1 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.0 | 1.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 0.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.0 | 3.5 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 1.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.0 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.0 | 0.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
| 0.0 | 0.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.0 | 1.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.0 | 0.1 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.0 | 1.1 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.0 | 2.1 | GO:0004620 | phospholipase activity(GO:0004620) |
| 0.0 | 0.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.0 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.0 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.0 | 0.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.0 | 1.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.0 | 2.1 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 0.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
| 0.0 | 0.4 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
| 0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.0 | 2.8 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.0 | 2.3 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
| 0.0 | 2.8 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
| 0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.0 | 1.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.0 | 0.4 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
| 0.0 | 0.6 | GO:0016829 | lyase activity(GO:0016829) |
| 0.0 | 0.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.0 | 1.6 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.0 | 3.1 | GO:0008270 | zinc ion binding(GO:0008270) |
| 0.0 | 0.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 1.0 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.0 | 0.8 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
| 0.0 | 0.5 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
| 0.0 | 0.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.0 | 0.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.0 | 0.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.0 | 3.4 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.0 | 0.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.0 | 1.9 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.0 | 0.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.0 | 0.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.0 | 0.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.0 | 0.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 0.8 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.0 | 2.9 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
| 0.0 | 0.4 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.0 | 0.4 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.0 | 0.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.0 | 0.1 | GO:0043426 | MRF binding(GO:0043426) |
| 0.0 | 0.0 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 0.0 | 0.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.1 | 8.1 | PID BMP PATHWAY | BMP receptor signaling |
| 0.1 | 2.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.1 | 3.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.1 | 2.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.1 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.1 | 15.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 1.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.0 | 1.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 2.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 2.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 1.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 1.9 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.0 | 1.8 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 2.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 2.1 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.0 | 7.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 1.2 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.0 | 3.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 1.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 0.9 | PID ATR PATHWAY | ATR signaling pathway |
| 0.0 | 2.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.0 | 0.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.0 | 0.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 2.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.0 | 0.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.0 | 1.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 0.9 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.0 | 1.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.0 | 1.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.0 | 7.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 1.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 1.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 0.8 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.0 | 1.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.0 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.0 | 1.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 0.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 1.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 1.2 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 1.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.0 | 0.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 3.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.2 | 14.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.2 | 2.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.2 | 3.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.2 | 1.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.1 | 5.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 2.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.1 | 4.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 5.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 1.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.1 | 4.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.1 | 5.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 3.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 1.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.1 | 2.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.1 | 3.0 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.1 | 1.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.1 | 2.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 2.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.0 | 1.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.0 | 1.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.0 | 1.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.0 | 0.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.0 | 1.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.0 | 1.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.0 | 2.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.0 | 2.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 3.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 0.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.0 | 3.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.0 | 0.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.0 | 0.7 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.0 | 0.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.0 | 0.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.0 | 3.6 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.0 | 0.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 0.5 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.0 | 0.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.0 | 3.0 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
| 0.0 | 3.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 0.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.0 | 0.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.0 | 0.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.0 | 0.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.0 | 1.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.0 | 0.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.0 | 1.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 2.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 0.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.0 | 0.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 0.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 1.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.0 | 0.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |